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Abstract Acridone synthase (ACS) and chalcone synthase
(CHS) catalyse the pivotal reactions in the formation of acridone
alkaloids or flavonoids. While acridone alkaloids are confined
almost exclusively to the Rutaceae, flavonoids occur abundantly
in all seed-bearing plants. ACSs and CHSs had been cloned from
Ruta graveolens and shown to be closely related polyketide
synthases which use N-methylanthraniloyl-CoA and 4-coumar-
oyl-CoA, respectively, as the starter substrate to produce the
acridone or naringenin chalcone. As proposed for the related 2-
pyrone synthase from Gerbera, the differential substrate
specificities of ACS and CHS might be attributed to the relative
volume of the active site cavities. The primary sequences as well
as the immunological cross reactivities and molecular modeling
studies suggested an almost identical spatial structure for ACS
and CHS. Based on the Ruta ACS2 model the residues Ser132,
Ala133 and Val265 were assumed to play a critical role in
substrate specificity. Exchange of a single amino acid
(Val265Phe) reduced the catalytic activity by about 75% but
grossly shifted the specificity towards CHS activity, and site-
directed mutagenesis replacing all three residues by the
corresponding amino acids present in CHS (Ser132Thr, Ala133-
Ser and Val265Phe) fully transformed the enzyme to a functional
CHS with comparatively marginal ACS activity. The results
suggested that ACS divergently has evolved from CHS by very
few amino acid exchanges, and it remains to be established why
this route of functional diversity has developed in the Rutaceae
only. ß 2001 Federation of European Biochemical Societies.
Published by Elsevier Science B.V. All rights reserved.
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1. Introduction
Acridone synthase (ACS) and chalcone synthase (CHS) cat-
alyse the condensation of N-methylanthraniloyl-CoA or 4-
coumaroyl-CoA with three units of malonyl-CoA to yield
1,3-dihydroxy-N-methylacridone and naringenin chalcone, re-
spectively (Fig. 1). The enzymes belong to a superfamily of
plant polyketide synthases (PKSs) [1] forming numerous sec-
ondary metabolites, which include stilbene synthase (STS) [2],
bibenzyl synthase [3], 2-pyrone synthase [4] and others. PKSs
have been characterised as homodimers [1,5] of approximately
45 kDa subunits, and, in the case of CHS and STS, each
subunit was shown to be capable of conducting all three
rounds of condensation, although the dimerisation is essential
for catalytic activity [1]. CHSs have been cloned and expressed
from a number of plants [1], and the synthase from Medicago
sativa was ¢rst crystallised for X-ray di¡raction analysis [6].
The spatial model of this enzyme, together with the data from
previous sequence alignments as well as from site-directed
mutagenesis and kinetic studies, assigned four amino acid
residues (Cys164, Phe215, His303 and Asn336) to the decar-
boxylation and condensation reactions [6,7]. Cys164 is re-
quired as a nucleophile for the Claisen condensation reaction,
while His303 and Asn336 were suggested to facilitate the de-
carboxylation of malonyl-CoA to the nucleophilic acetyl-CoA
carbanion which promotes the chain extension [6^8]. The
spacing of these three amino acid residues is remarkably con-
served in all plant PKSs, including the ACSs, and even in a
number of bacterial PKSs [7].
In contrast to the abundant CHSs, ACSs appear to be
con¢ned to the Rutaceae family [9] and one species of the
Piperaceae [10], and it appears likely that ACS has evolved
from CHS by gene duplication and nucleotide substitution
shifting the enzyme function [11]. Two ACS and three CHS
cDNAs cloned from Ruta graveolens L. had been shown to
encode highly homologous polypeptides (about 75%), and the
functional expression of ACS1 and 2 and CHS1 in Escherichia
coli con¢rmed the di¡erent substrate speci¢cities. CHS1 did
not accept N-methylanthraniloyl-CoA as a starter substrate,
while ACS1 and 2 predominantly used N-methylanthraniloyl-
CoA but showed signi¢cant CHS side activities (up to roughly
20%) in assays with 4-coumaroyl-CoA [12]. Minor side activ-
ities (95%) appear to be common among the PKSs and have
been reported, for example, for CHS from Pueraria lobata
(STS activity) and STS from Arachis hypogaea (CHS activity)
[13] or 2-pyrone synthase from Gerbera hybrida (acetyl-CoA
or benzoyl-CoA as starter substrates) [14]. The three-dimen-
sional structure of Medicago CHS predicted a bilobed initia-
tion/elongation cavity, one lobe hosting the coumaroyl bind-
ing pocket while the other accommodates the growing
polyketide chain, and the size of the cavity was considered
to limit the access of starter substrates [4]. Nevertheless, a
less stringent Scutellaria CHS was reported recently, which
accepted starter substrates bulkier than 4-coumaroyl-CoA
[15] but failed to aromatise the resulting tetraketide intermedi-
ates. Thus, the cyclisation appears to be independent of the
condensation reactions and under topological control as pro-
posed earlier for CHS and STS [16]. An essential e¡ect on the
tetraketide folding and cyclisation was ascribed recently to the
amino acids 372^376 (GFGPG) in Pueraria CHS and Arachis
STS lining the enzymes’ active site [17].
ACS and CHS catalyse analogous condensations up to the
tetraketide stage, but subtle di¡erences exist in the modes of
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cyclisation. The ¢nal bridging of rings in acridone biosynthe-
sis must formally proceed from a non-aromatic ‘trione’ inter-
mediate [18] followed by dehydration prior to the aromatisa-
tion (Fig. 1). In contrast, CHS releases the chalcone as the
immediate product which in the absence of chalcone isomer-
ase cyclises non-stereoselectively to the £avanone naringenin.
Furthermore, the size of the active site cavity in ACS versus
CHS might determine the choice of starter substrate, consid-
ering the di¡erent molecular dimensions of N-methylanthra-
niloyl- and 4-coumaroyl-CoAs. Based on the structural mod-
els of Medicago CHS and Gerbera 2-pyrone synthase [4], the
CHS had been transformed to a 2-pyrone synthase, utilising
acetyl-CoA as a starter substrate in vitro, by introducing three
mutations that restricted the space in the active site fold.
Accordingly, the restriction of the active site cavity of ACS
was examined in this report in order to eventually reverse the
natural evolutionary process and to generate a functional
CHS.
2. Materials and methods
2.1. Chemicals and materials
All biochemicals were of analytical grade. Materials, vectors, E. coli
host strains, restriction enzymes and DNA modifying enzymes were
purchased from previously cited sources [5,12].
2.2. Data base search and three-dimensional homology modeling
Data bank retrieval and sequence alignments were done with the
Entrez or Blast software (National Library of Medicine and National
Institute of Health, Bethesda, MD, USA). A standard homology
modeling procedure was applied, based on the sequence homology
(about 75% identity) of ACS and CHSs (Fig. 2B) and the X-ray
structure of alfalfa CHS [6], to predict the three-dimensional structure
of ACS for the selection of mutation sites. The model of ACS (Fig.
2A) was produced using the tools of the Swiss-model package (http://
expasy.ch/spdbv/) provided by the Swiss-PDB-Viewer program [19].
The corresponding Ramachandran plot was also created with the
Swiss PDB-Viewer software to con¢rm that the majority of residues
grouped in the energetically allowed regions.
2.3. ACS mutation
Based on the ACS II-pTZ19R plasmid [5], the ACS2 mutants MS1,
MS2, MS3.1 and MS3.2 were generated by site-directed mutagenesis
following the procedure of Kunkel et al. [20] and using an in vitro
mutagenesis technique with custom-synthesised oligonucleotide prim-
ers (G. Igloi, Institut fu«r Biologie III, Universita«t Freiburg). MS1
encoded the amino acid substitutions Arg146Lys, Met147Leu, Asn-
151Arg, Met157Phe and Ile159Met, which were introduced with the
oligonucleotide primer (nucleotide substitutions as compared to the
ACS2 wild-type underlined) 5P-TTG TTG ATA CAT CAT GAA
ACG CTT AAC GGA CGG CCT GAG GCC GAG CAG TTT
CGT CAG-3P. MS2 produced the amino acid substitutions
Pro203Asp, Asp204Thr and Ala205His by mutation with the oligo-
nucleotide primer 5P-CAC TAG CGA ATC AAC ATG GGT GTC
TGA CGG GCC ACG G-3P. MS3.1 encoded the exchange Val265Phe
introduced with the primer 5P-C TTT CTT TAG ATG AAA TGT
GAG ACC-3P, and MS3.2 encoded the substitutions Ser132Thr and
Ala133Ser generated with the primer 5P-ATC GAC GCC GGA TGT
TGT GCA GAA AAT-3P in addition to Val265Phe. Each mutant was
veri¢ed by didesoxy chain termination DNA sequencing [21] of the
full-size ACS gene using the universal and reverse sequencing primers.
The construction of expression vectors was performed with standard
techniques [22], the wild-type or mutant ACS cDNA was spliced from
ACS-pTZ19R constructs with NcoI and PstI, and the inserts were
subcloned into the expression vector pQE6 [5]. E. coli M15, harbour-
ing the plasmid pRep4, was transformed with the wild-type and mu-
tant ACS-pQE6 constructs, and the cells were propagated, induced
for ACS expression and harvested as described previously [5]. Crude
bacterial extracts were prepared by ultrasonication, and the enzyme
activities were assayed from the clear supernatant after centrifugation
(30 000Ug, 4‡C, 10 min).
2.4. General assays
ACS antibodies were raised in a New Zealand White rabbit by
repeated injections [23] of approximately 1 mg total of homogeneous
ACS2 [5], and the 10 000-fold diluted antiserum was used for blotting
experiments. The protein composition of samples was examined by
sodium dodecyl sulphate^polyacrylamide gel electrophoresis (PAGE)
[24] and Western blotting [25], and protein amounts were determined
after precipitation with trichloroacetic acid according to Lowry [26]
with bovine serum albumin as a reference. ACS and CHS activity
assays were performed with 50 WM N-methylanthraniloyl-CoA
(ACS) or 4-coumaroyl-CoA (CHS) in the presence of 15WM [2-14C]-
malonyl-CoA (7U104 dpm) in a total volume of 100 Wl employing
60 Wg of the crude bacterial protein [5,12]. All determinations were
made in triplicate at least. The products were extracted from the
incubations and identi¢ed by radio-thin layer chromatography on
silica gel in toluene/ethylacetate 6:4 (1,3-dihydroxy-N-methylacridone
from ACS assays) or on cellulose in 20% acetic acid (naringenin from
CHS assays).
3. Results and discussion
3.1. Consideration of ACS structure and mutation sites
The primary sequences of ACSs revealed more than 75%
homology to CHS sequences from Ruta and other plant spe-
cies [5]. This is in the same order as the homology observed on
comparison of Medicago CHS with Gerbera 2-pyrone syn-
thase [4], two PKSs for which almost identical structural mod-
els have been deduced from X-ray di¡raction analysis. Con-
ceivably, this applies also to ACS, and antibodies generated to
recombinant Ruta ACS2 readily crossreacted with heterolo-
gous CHSs and vice versa (Lukac›in et al., unpublished). Fur-
thermore, the circular dichroism (CD) spectra of ACS and
CHS isolated from Ruta are superimposable (Lukac›in et al.,
unpublished) and suggested that ACS and CHS adopt an
equivalent con¢guration. Based on the Medicago CHS prece-
dent, therefore, the three-dimensional ACS structure can be
predicted by a standard homology modeling procedure (Fig.
2A). In the Ramachandran plot calculated for this ACS model
most amino acid residues group in the energetically allowed
regions with only few exceptions, primarily glycine residues
which can adopt phi and psi angles in all four quadrants.
Alignments of the Ruta ACS and CHS polypeptides with
the Medicago CHS2 sequence (Fig. 2B) highlighted only a few
di¡erences for the Ruta enzymes, which appeared attractive
for mutational studies. The ACS contains a prominent Pro203-
Asp-Ala motif which is not conserved in any other member of
the PKS family (Fig. 2B). This tripeptide motif might contrib-
ute to the substrate speci¢city, although the computer-gener-
ated ACS model placed this motif distant from the active site
cavity (Fig. 2A). Ruta ACS, like all PKSs, contains a strictly
conserved cysteine residue (Cys164, Fig. 2B) at the active site
Table 1
Relative ACS and CHS activities of the wild-type and mutant
ACS2 enzymes
Enzyme Relative speci¢c activity (%)
ACS CHS
Wild-type ACS 100 þ 5 14.5 þ 0.5
Val265Phea 26 þ 1 29 þ 2
Triple-mutanta 36 þ 3 370 þ 15
aThe mutants were generated by exchange of one (Val265Phe) or
three residues (Ser132Thr, Thr133Ala and Val265Phe) lining the ac-
tive site pocket. The speci¢c ACS activity reached 1 Wkat/kg on
average. For comparison, the catalytic activity of Ruta endogeneous
CHS1 reached a level twice as high as the CHS activity of the ACS
triple mutant.
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[1], which in CHSs is commonly embedded in a conserved
sequence context. Surprisingly, in the ACS sequences
Asn151 replaced the Arg151 residue found in CHS sequences
(Fig. 2B). While the proximity to the active site cysteine and
the charge of this substitution might suggest a role in sub-
strate speci¢city, the ACS model excluded this asparagine res-
idue from the active site binding pocket (Fig. 2A). However,
the homology model suggested that Val265, Ser132 and
Ala133 residues might be involved in substrate binding (Fig.
2A). These amino acids line the active site cavity of ACS and
are not conserved in other members of the PKS family.
3.2. Transformation of ACS into CHS
Four ACS mutants (MS1, MS2, MS3.1 and MS3.2) were
generated by site-directed mutagenesis of the open reading
frame of Ruta ACS2 cDNA (Fig. 2B) aiming to confer CHS
activity on the translation product. The cDNAs were cloned
into the vector pQE6, and the wild-type and mutant genes
were expressed in E. coli strain M15prep4. The mutant en-
zymes were expressed upon isopropyl L-D-thiogalactopyrano-
side (IPTG) induction as soluble polypeptides just like the
wild-type ACS2, and the cross-reaction with the ACS2 anti-
bodies in all instances produced only one band of comparable
intensity. Western blotting of crude extracts of the induced,
recombinant bacteria revealed that the expression levels of
mutant polypeptides were equivalent to that of the wild-type
enzyme.
Initially, the mutants MS1 and MS2 were assayed for their
enzyme activities. MS1 encoded ¢ve amino acid substitutions
clustering in the proximity of the strictly conserved Cys164
(Fig. 2B), while in MS2 the Pro203-Asp-Ala motif was re-
placed by the Asp-Thr-His tripeptide commonly found in
CHS sequences (Fig. 2B). In support of the ACS homology
model (Fig. 2A), neither of these mutations a¡ected the over-
all activity or the starter substrate speci¢city to a signi¢cant
extent (ACS to CHS ratios of 7:1 þ 10%). The Val265Phe
substitution in the mutant MS3.1 (Fig. 2B) reduced the spe-
ci¢c enzyme activity by about 75% in comparison to wild-type
ACS2 (Table 1), which nevertheless suggested that this residue
is not essential for ACS activity. However, the mutation con-
siderably shifted the starter substrate preference to 4-cou-
maroyl-CoA and hence transformed the enzyme to a CHS
with high ACS side activity (Table 1). This e¡ect was drasti-
cally enhanced by exchanging further two amino acids,
Ser132Thr and Ala133Ser (Fig. 2B), which were also supposed
to line the ACS substrate binding pocket (Fig. 2A) in the
mutant MS 3.2. The triple mutant retained about 35% of
the ACS activity of the wild-type enzyme, but represented a
functional CHS (Table 1) by showing 10-fold higher speci¢c
CHS activity (Table 1) emphasising the much higher total
activity. Thus, the structural prediction by standard homology
modeling, although less reliable than X-ray crystallography,
provided su⁄cient information on the substrate binding site
of ACS to suggest the essential points of mutation. With
reference to this model (Fig. 2A), the mutations in MS3.1
and MS3.2, in particular, must have signi¢cantly altered the
space and/or charge restrictions of the active site pocket, and
the di¡erence in geometry caused the change in the starter
Fig. 1. Reactions catalysed by ACS or CHS. Di¡erent modes of cyclisation of the linear tetraketide intermediates are catalysed by ACS or
CHS. The cyclisation of the hypothetical trione intermediate to N-methylacridone by ACS proceeds through nucleophilic substitution followed
by dehydration, while CHS immediately aromatises the intermediate.
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substrate preference. The results demonstrate that few muta-
tional changes are su⁄cient to alter the functionality of CHS,
and the mutants MS3.1 and MS3.2 might be considered as
intermediates in the molecular evolution of PKSs diversity. It
should be noted that the conversion of ACS to CHS as docu-
mented in this report appears easier than the opposite, since
CHSs including the one from Ruta, don’t show any ACS side
activity.
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